866-997-4948(US-Canada Toll Free)

Europe Non-Insulin Therapies for Diabetes Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Insulin

No. of Pages : 124 Pages

Notes:
Sales, means the sales volume of Non-Insulin Therapies for Diabetes
Revenue, means the sales value of Non-Insulin Therapies for Diabetes

This report studies sales (consumption) of Non-Insulin Therapies for Diabetes in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Non-Insulin Therapies for Diabetes in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Alpha-Glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides/Meglitinides
GLP-1 Analogs/GLP-1 Agonists
Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
Sulfonylureas
Thiazolidinediones
Others

Split by application, this report focuses on sales, market share and growth rate of Non-Insulin Therapies for Diabetes in each application, can be divided into
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

Table of Contents

Europe Non-Insulin Therapies for Diabetes Market Report 2017
1 Non-Insulin Therapies for Diabetes Overview
1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes
1.2 Classification of Non-Insulin Therapies for Diabetes
1.2.1 Alpha-Glucosidase Inhibitors
1.2.2 Amylin Agonists
1.2.3 Biguanides
1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.5 Glinides/Meglitinides
1.2.6 GLP-1 Analogs/GLP-1 Agonists
1.2.7 Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
1.2.8 Sulfonylureas
1.2.9 Thiazolidinediones
1.2.10 Others
1.3 Application of Non-Insulin Therapies for Diabetes
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacy
1.3.4 Others
1.4 Non-Insulin Therapies for Diabetes Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Non-Insulin Therapies for Diabetes (2012-2022)
1.5.1 Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)
1.5.2 Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

2 Europe Non-Insulin Therapies for Diabetes by Manufacturers, Type and Application
2.1 Europe Non-Insulin Therapies for Diabetes Market Competition by Manufacturers
2.1.1 Europe Non-Insulin Therapies for Diabetes Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Non-Insulin Therapies for Diabetes Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Non-Insulin Therapies for Diabetes (Volume and Value) by Type
2.2.1 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)
2.2.2 Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
2.3 Europe Non-Insulin Therapies for Diabetes (Volume and Value) by Countries
2.3.1 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Countries (2012-2017)
2.4 Europe Non-Insulin Therapies for Diabetes (Volume) by Application

3 Germany Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
3.1 Germany Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
3.1.1 Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
3.1.2 Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
3.1.3 Germany Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
3.2 Germany Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
3.3 Germany Non-Insulin Therapies for Diabetes Sales and Market Share by Type
3.4 Germany Non-Insulin Therapies for Diabetes Sales and Market Share by Application

4 France Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
4.1 France Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
4.1.1 France Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
4.1.2 France Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
4.1.4 France Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
4.2 France Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
4.3 France Non-Insulin Therapies for Diabetes Sales and Market Share by Type
4.4 France Non-Insulin Therapies for Diabetes Sales and Market Share by Application

5 UK Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
5.1 UK Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
5.1.1 UK Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
5.1.2 UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
5.1.5 UK Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
5.2 UK Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
5.3 UK Non-Insulin Therapies for Diabetes Sales and Market Share by Type
5.4 UK Non-Insulin Therapies for Diabetes Sales and Market Share by Application

6 Russia Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
6.1 Russia Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
6.1.1 Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
6.1.2 Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
6.1.6 Russia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
6.2 Russia Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
6.3 Russia Non-Insulin Therapies for Diabetes Sales and Market Share by Type
6.4 Russia Non-Insulin Therapies for Diabetes Sales and Market Share by Application

7 Italy Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
7.1 Italy Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
7.1.1 Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
7.1.2 Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
7.1.7 Italy Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
7.2 Italy Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
7.3 Italy Non-Insulin Therapies for Diabetes Sales and Market Share by Type
7.4 Italy Non-Insulin Therapies for Diabetes Sales and Market Share by Application

8 Spain Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
8.1 Spain Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
8.1.1 Spain Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
8.1.2 Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
8.1.8 Spain Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
8.2 Spain Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
8.3 Spain Non-Insulin Therapies for Diabetes Sales and Market Share by Type
8.4 Spain Non-Insulin Therapies for Diabetes Sales and Market Share by Application

9 Benelux Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
9.1 Benelux Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
9.1.1 Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
9.1.2 Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
9.2 Benelux Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
9.3 Benelux Non-Insulin Therapies for Diabetes Sales and Market Share by Type
9.4 Benelux Non-Insulin Therapies for Diabetes Sales and Market Share by Application

10 Europe Non-Insulin Therapies for Diabetes Manufacturers Analysis
10.1 GSK
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.1.2.1 Alpha-Glucosidase Inhibitors
10.1.2.2 Amylin Agonists
10.1.3 GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Eli Lilly
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.2.2.1 Alpha-Glucosidase Inhibitors
10.2.2.2 Amylin Agonists
10.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Sumitomo Dainippon Pharma
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.3.2.1 Alpha-Glucosidase Inhibitors
10.3.2.2 Amylin Agonists
10.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Intarcia Therapeutics
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.4.2.1 Alpha-Glucosidase Inhibitors
10.4.2.2 Amylin Agonists
10.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Servier
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.5.2.1 Alpha-Glucosidase Inhibitors
10.5.2.2 Amylin Agonists
10.5.3 Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Jiangsu Hansoh Pharmaceutical
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.6.2.1 Alpha-Glucosidase Inhibitors
10.6.2.2 Amylin Agonists
10.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.7.2.1 Alpha-Glucosidase Inhibitors
10.7.2.2 Amylin Agonists
10.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Emisphere
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.8.2.1 Alpha-Glucosidase Inhibitors
10.8.2.2 Amylin Agonists
10.8.3 Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Uni-Bio Science Group
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.9.2.1 Alpha-Glucosidase Inhibitors
10.9.2.2 Amylin Agonists
10.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Takeda
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
10.10.2.1 Alpha-Glucosidase Inhibitors
10.10.2.2 Amylin Agonists
10.10.3 Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 3SBio
10.12 Merck
10.13 Dong-A Pharmaceutical
10.14 Luye Pharma Group
10.15 Eurofarma
10.16 Geropharm
10.17 Alkem Labs
10.18 SatRx
10.19 Pfizer
10.20 Jiangsu Hengrui Medicine

11 Non-Insulin Therapies for Diabetes Manufacturing Cost Analysis
11.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Non-Insulin Therapies for Diabetes Market Forecast (2017-2022)
14.1 Germany Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.2 France Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.3 UK Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.4 Russia Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.5 Italy Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.6 Spain Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.7 Benelux Non-Insulin Therapies for Diabetes Sales Forecast (2017-2022)
14.8 Europe Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)
14.9 Europe Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Non-Insulin Therapies for Diabetes
Table Classification of Non-Insulin Therapies for Diabetes
Figure Europe Sales Market Share of Non-Insulin Therapies for Diabetes by Type in 2015
Figure Alpha-Glucosidase Inhibitors Picture
Figure Amylin Agonists Picture
Figure Biguanides Picture
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Picture
Figure Glinides/Meglitinides Picture
Figure GLP-1 Analogs/GLP-1 Agonists Picture
Figure Sodium-Glucose Cotransporter2(SGLT2)Inhibitors Picture
Figure Sulfonylureas Picture
Figure Thiazolidinediones Picture
Figure Others Picture
Table Application of Non-Insulin Therapies for Diabetes
Figure Europe Sales Market Share of Non-Insulin Therapies for Diabetes by Application in 2015
Figure Hospital Pharmacy Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacy Examples
Figure Others Examples
Figure Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure France Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Table Europe Non-Insulin Therapies for Diabetes Sales of Key Manufacturers (2015 and 2016)
Table Europe Non-Insulin Therapies for Diabetes Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Insulin Therapies for Diabetes Sales Share by Manufacturers
Figure 2016 Non-Insulin Therapies for Diabetes Sales Share by Manufacturers
Table Europe Non-Insulin Therapies for Diabetes Revenue by Manufacturers (2015 and 2016)
Table Europe Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers
Table 2016 Europe Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers
Table Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Sales Growth Rate by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Revenue Growth Rate by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Countries (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales Share by Countries (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Countries (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Revenue and Market Share by Countries (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Countries (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Application (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Application (2012-2017)
Figure Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Germany Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Germany Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table Germany Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table Germany Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table Germany Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table Germany Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table Germany Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Figure France Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure France Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure France Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table France Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table France Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table France Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table France Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table France Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table France Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Figure UK Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure UK Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table UK Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table UK Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table UK Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table UK Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table UK Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table UK Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Figure Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Russia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Russia Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table Russia Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table Russia Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table Russia Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table Russia Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table Russia Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Figure Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Italy Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Italy Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table Italy Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table Italy Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table Italy Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table Italy Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table Italy Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Figure Spain Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Spain Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Spain Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table Spain Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table Spain Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table Spain Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table Spain Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table Spain Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Figure Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Benelux Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Benelux Non-Insulin Therapies for Diabetes Sales by Manufacturers (2015 and 2016)
Table Benelux Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2015 and 2016)
Table Benelux Non-Insulin Therapies for Diabetes Sales by Type (2015 and 2016)
Table Benelux Non-Insulin Therapies for Diabetes Market Share by Type (2015 and 2016)
Table Benelux Non-Insulin Therapies for Diabetes Sales by Application (2015 and 2016)
Table Benelux Non-Insulin Therapies for Diabetes Market Share by Application (2015 and 2016)
Table Non-Insulin Therapies for Diabetes Basic Information List
Table GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Sumitomo Dainippon Pharma Basic Information List
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Intarcia Therapeutics Basic Information List
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Servier Basic Information List
Table Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Servier Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Jiangsu Hansoh Pharmaceutical Basic Information List
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Emisphere Basic Information List
Table Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Emisphere Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Uni-Bio Science Group Basic Information List
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Non-Insulin Therapies for Diabetes Sales Market Share (2012-2017)
Table 3SBio Basic Information List
Table Merck Basic Information List
Table Dong-A Pharmaceutical Basic Information List
Table Luye Pharma Group Basic Information List
Table Eurofarma Basic Information List
Table Geropharm Basic Information List
Table Alkem Labs Basic Information List
Table SatRx Basic Information List
Table Pfizer Basic Information List
Table Jiangsu Hengrui Medicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Insulin Therapies for Diabetes
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Non-Insulin Therapies for Diabetes Industrial Chain Analysis
Table Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
Table Major Buyers of Non-Insulin Therapies for Diabetes
Table Distributors/Traders List
Figure Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure Germany Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure France Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure France Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure UK Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure UK Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure Russia Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure Italy Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure Spain Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Table Europe Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)
Table Europe Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *